TAK - Takeda Pharmaceutical Company Limited

NYSE - NYSE Delayed Price. Currency in USD
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 6/8/2020
Current
3/31/202012/31/20199/30/20196/30/2019
Market Cap (intraday) 5
57.67B47.68B61.97B53.24B55.15B
Enterprise Value 3
98.35B90.55B102.99B99.91B101.78B
Trailing P/E
143.39N/AN/A32.9033.81
Forward P/E 1
17.2712.8516.9830.21117.65
PEG Ratio (5 yr expected) 1
0.230.410.540.932.92
Price/Sales (ttm)
1.931.572.021.721.76
Price/Book (mrq)
1.341.051.381.191.15
Enterprise Value/Revenue 3
0.030.120.120.120.12
Enterprise Value/EBITDA 6
0.141.680.600.460.52

Trading Information

Stock Price History

Beta (5Y Monthly) 1.11
52-Week Change 3-2.73%
S&P500 52-Week Change 35.67%
52 Week High 320.93
52 Week Low 312.43
50-Day Moving Average 318.62
200-Day Moving Average 318.10

Share Statistics

Avg Vol (3 month) 31.19M
Avg Vol (10 day) 3918.38k
Shares Outstanding 53.12B
Float 3B
% Held by Insiders 10.00%
% Held by Institutions 14.23%
Shares Short (Jun 14, 2020) 42.16M
Short Ratio (Jun 14, 2020) 41.77
Short % of Float (Jun 14, 2020) 4N/A
Short % of Shares Outstanding (Jun 14, 2020) 40.07%
Shares Short (prior month May 14, 2020) 42.14M

Dividends & Splits

Forward Annual Dividend Rate 40.84
Forward Annual Dividend Yield 44.79%
Trailing Annual Dividend Rate 31.63
Trailing Annual Dividend Yield 39.35%
5 Year Average Dividend Yield 43.74
Payout Ratio 4634.84%
Dividend Date 3Dec 14, 2009
Ex-Dividend Date 4Mar 29, 2020
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in JPY.

Fiscal Year

Fiscal Year Ends Mar 30, 2020
Most Recent Quarter (mrq)Mar 30, 2020

Profitability

Profit Margin 1.34%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)1.40%
Return on Equity (ttm)0.89%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)7.60%
Gross Profit (ttm)2.2T
EBITDA N/A
Net Income Avi to Common (ttm)N/A
Diluted EPS (ttm)0.81
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)115.55
Current Ratio (mrq)1.13
Book Value Per Share (mrq)12.55

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A